Avalo Therapeutics Cash from Operations (TTM) Analysis

Avalo Therapeutics Inc (AVTX)

12.95 -0.68 (-4.99%) USD | NASDAQ | Apr 18, 09:45

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-30.68M
September 30, 2023	-31.85M
June 30, 2023	-19.29M
March 31, 2023	-20.74M
December 31, 2022	-26.75M
September 30, 2022	-39.91M
June 30, 2022	-61.93M
March 31, 2022	-68.64M
December 31, 2021	-70.89M
September 30, 2021	-68.17M
June 30, 2021	-63.75M
March 31, 2021	-53.12M
December 31, 2020	-40.54M
September 30, 2020	-27.84M
June 30, 2020	-23.59M
March 31, 2020	-21.75M
December 31, 2019	-19.13M
September 30, 2019	-19.43M
June 30, 2019	-12.35M

Date	Value
March 31, 2019	-5.969M
December 31, 2018	-3.128M
September 30, 2018	-3.702M
June 30, 2018	15.96M
March 31, 2018	14.53M
December 31, 2017	12.58M
September 30, 2017	11.41M
June 30, 2017	-11.14M
March 31, 2017	-13.10M
December 31, 2016	-14.57M
September 30, 2016	-14.41M
June 30, 2016	-12.79M
March 31, 2016	-10.80M
December 31, 2015	-10.16M
September 30, 2015	-10.58M
June 30, 2015	-15.87M
March 31, 2015	-16.38M
December 31, 2014	-15.52M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-70.89M

Minimum

Dec 2021

-12.35M

Maximum

Jun 2019

-37.91M

Average

-30.68M

Median

Dec 2023

Cash from Operations (TTM) Benchmarks